CAR-T cells

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

CAR-T cells
Jan 3, 2025, 13:00 | Blog
The current treatment process with CAR T cells - Penn Medicine
Penn Medicine, University of Pennsylvania Health System shared a post on LinkedIn: "CAR T cells…
Dec 28, 2024, 14:04 | Blog
Francisco Conesa Buendía: FAS-Less Allogeneic CAR-T Cells - A Leap Towards Off-the-Shelf Cancer Therapies
Francisco Conesa Buendía, Assistant in Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Dec 26, 2024, 14:47 | Blog
Rahul Purwar: Make in India CAR-T Cells Gene therapy accessible to all patients
Rahul Purwar, Associate Professor at IIT Bombay, shared a post on X: "Huge thanks to…
Nov 26, 2024, 14:57 | Blog
Derek A. Wainwright: Crystal Mackall delivers Keynote Address on CAR T cells for Brain Cancer
Derek A. Wainwright, Scientific Director for Brain Tumor Research and Associate Professor at Loyola Medicine,…
Nov 12, 2024, 19:38 | Blog
Alfredo Colina on comparing real-time multimodal analysis of CAR-T cells to more traditional phenotypic and functional assays
Anthony Zamora, Assistant Professor at Medical College of Wisconsin, reshared a post by Alfredo Colina,…
Nov 12, 2024, 11:04 | Blog
Angela Mastronuzzi: 54th SIN CONGRESS ROME 2024
Angela Mastronuzzi, Pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital,…
Nov 12, 2024, 00:43 | Blog
Aaron Sverdlov: The Right Heart in Patients with Cancer
Aaron Sverdlov, Professor and Director of Heart Failure and Co-Director at Newcastle Centre of Excellence…
Oct 30, 2024, 13:33 | Blog
Francisco Conesa Buendía: How CRISPR is shaping the future of CAR T-cell therapy
Francisco Conesa Buendía, Cell and Gene Therapies Manufacturing Assistant at Memorial Sloan Kettering Cancer Center,…
Oct 18, 2024, 16:08 | Insight
Brandon Imber: Effective cytoreduction improves outcomes for CAR T cell patients
Brandon Imber, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, posted the following on X: “Effective…
Sep 21, 2024, 10:35 | Blog
Hung Trinh: The use of chimeric antigen receptor (CAR)-T cells has demonstrated excellent results in B-lymphoid malignancies
Hung Trinh shared a post on LinkedIn: "CAR-T cells targeting IL-1RAP produced in a closed semiautomatic…
Sep 18, 2024, 14:06 | Blog
Maximilian Merz: A comeback of checkpoint inhibition in Multiple Myeloma
Maximilian Merz, Head of Early Clinical Trials Unit Leipzig (ECTUL) at Leipzig University, shared a…
Sep 1, 2024, 08:17 | Insight
CAR T cells to discover and target vulnerabilities in invasive brain cancer
Sheila Singh Brain Tumour Lab shared on X: “We are happy to share the 'research…
Aug 25, 2024, 15:49 | Insight
New strategies to enable CAR T cells to overcome the major hurdles in solid tumors - CRI
Cancer Research Institute (CRI) shared on LinkedIn: "While CAR T cell therapy has made transformational…
Aug 20, 2024, 05:20 | Dialogues
Low-Grade Lymphomas: Dr. Joshua Brody on Treatments, Strategies, and Innovations
In this episode of OncoDaily interviews, Dr. Joshua Brody, director of the lymphoma immunotherapy program…
Aug 3, 2024, 01:46 | Blog
Saba Ghassemi: Honored to receive my first NIH R01 grant to explore the role of IFN1 signaling in nonactivated CAR T cells
Saba Ghassemi, Research Assistant Professor at University of Pennsylvania School of Medicine, shared a post…
Aug 1, 2024, 08:32 | Insight
Rahul Banerjee: A 'CAR-E' - basically a care package for CAR T-cells as they start their first jobs
Rahul Banerjee, Assistant Professor at UW Medicine, shared a posts by Mohammad Rashidian, Assistant Professor, Dana-Farber Cancer Institute,…
Jul 31, 2024, 08:28 | Blog
Sonia Guedan: The CAR-T ARI0002h by IDIBAPS has been approved for multiple myeloma
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, shared a post on X: ''The CAR-T ARI0002h…
Jul 25, 2024, 18:24 | Insight
Myeloma Paper of the Day, July 25th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Retrospective study finds that, among BCMA-directed therapies,…
Jul 22, 2024, 07:18 | Blog
"Immunotherapy services are expanding to meet demand" - Mazyar Shadman
Fred Hutchinson Cancer Center shared on X: " 'One of the challenges we have in the…
Jul 10, 2024, 10:54 | Blog
HEROS 2.0 trial using CAR T-cells targeting HER2 protein has shown safety and clinical benefit - St. Baldrick's Foundation
St. Baldrick's Foundation shared on LinkedIn: "Exciting news on the horizon for sarcoma patients from…
Jun 18, 2024, 14:43 | Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 15, 2024, 06:13 | Blog
Snowdome Foundation announced the 2024 TRP recipient - Paul Beavis
Snowdome Foundation shared on LinkedIn: "The Snowdome Foundation is thrilled to announce the 2024 Translational Research…
May 31, 2024, 05:37 | Societies
A groundbreaking moment from 2017— the FDA approval of Kymriah - St. Baldrick's Foundation
St. Baldrick's Foundation shared a post on LinkedIn:  “Today, we're looking back on a groundbreaking…
May 28, 2024, 08:56 | Blog
Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix),…
May 28, 2024, 07:57 | Dialogues
Oncothon: Pediatric Oncology with Godfrey Chan, Nita Radhakrishnan
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 18, 2024, 11:35 | Insight
Elena Sotillo: Engineering CAR-T cells for combination therapy with CD47 blockade
Elena Sotillo, Senior Research Scientist at Stanford Cancer Institute, shared on LinkedIn: “New paper out…
May 13, 2024, 08:34 | Blog
Featured in the NIH catalyst - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: ''Featured in the NIH catalyst: Adam Sowalsky, a…
May 12, 2024, 16:18 | Insight
Patrick Hwu: Insights into CAR design and optimal coupling to inhibit the PD-L1/PD-1 axis
Patrick Hwu shared on X/Twitter: "Science Saturday T-cells gene-modified with chimeric antigen receptors (CAR) can be…
May 10, 2024, 11:42 | Insight
Moffitt Cancer Center Scientific Symposium
Moffitt Cancer Center shared on X:  “At Moffitt Scientific Symposium, Ashley Whitmer joined Patrick Hwu…
May 5, 2024, 13:13 | Blog
Dr. Tim Greten receives 2024 Innovation Grant from the Cholangiocarcinoma Foundation! - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "STAFF SPOTLIGHT: Congratulations to Dr. Tim Greten, the…
May 1, 2024, 11:43 | Blog
Angela Mastronuzzi: We dedicate May to brain tumor education
Angela Mastronuzzi shared on LinkedIn: "Today begins Brain Tumor Awareness Month. We dedicate May to…
Apr 28, 2024, 23:40 | Blog
Susanna Greer: Boosting the CAR T party
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
Apr 27, 2024, 12:37 | Blog
Renato Brito Baleeiro: Armoured CAR T-cells engineered to withstand the tumour immunosuppressive micro-environment of solid tumours
Renato Brito Baleeiro, Senior Scientist Project Lead at VacV Biotherapeutics, shared a post on LinkedIn:…
Apr 24, 2024, 22:41 | Blog
Breakdown of T cell therapies deployed to treat autoimmune diseases by Jeffrey C. Martin
Jeffrey C. Martin, Founder of Oncoleader, shared a post on LinkedIn: "T cell therapies are now…
Apr 20, 2024, 18:05 | Insight
Nicolas Hubacz: T Cell Vs Cancer Cell
Nicolas Hubacz, Research Products Business Development Manager at Magstim, shared a post on LinkedIn: "CAR…
Apr 16, 2024, 01:02 | Blog
CAR T cells can gain new vigor when engineered to have high levels of a particular protein - Cancer Research Institute
Cancer Research Institute posted on LinkedIn: "Bioengineered immune cells have been shown to attack and…
Apr 10, 2024, 08:41 | Drugs
Piotr Wysocki: CAR-T cells targeting CD70 for renal cell cancer – promising results of a phase I COBALT-RCC study (AACR2024)
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Mar 19, 2024, 20:14 | Blog
Vivek Subbiah: Nice to see CAR-T cells showing early signals of activity in Glioblastoma in a Phase 1
Vivek Subbiah shared a post on LinkedIn: "Nice to see CAR-T cells showing early signals of…
Mar 13, 2024, 09:23 | Blog
Katy Rezvani: Important study showing the promise of locoregional delivery of CAR-T cells in glioblastoma
Katy Rezvani, Chief, Section of Cellular Therapy at the Department of Stem Cell Transplantation and…
Mar 8, 2024, 22:36 | Blog
Vivek Subbiah: 'Far and away the best prize that life offers is the chance to work hard at work worth doing' — Theodore Roosevelt
Vivek Subbiah recently shared on LinkedIn: “'Far and away the best prize that life offers is…
Feb 23, 2024, 18:03 | Blog
Vivek Subbiah: The development of armored CAR T-cells may enable CAR T to be efficacious against a broader range of malignancies
Vivek Subbiah recently shared on LinkedIn: "'CARs are sharpening their weapons'. The development of armored…
Dec 27, 2023, 08:59 | Insight
Jonas Nilsson: Interesting and balanced discussion on a recent safety signal of CAR-T cells in plasma cell disorders
Jonas Nilsson Chair of Melanoma Discovery at The University of Western Australia and Harry Perkins…
Dec 10, 2023, 17:48 | Blog
Nick Vitanza: It's been a dream to bring better treatments to kids with DIPG and CNS tumors
Nick Vitanza, the Director of the Vitanza Lab at the Ben Towne Center for Childhood…
All: 43 Posts: 1 - 100
Special Coverage